<?xml version="1.0" ?>
<text author="Samantha  A Hutchinson, Priscilia Lianto, Hanne Roberg-Larsen, Sebastiano Battaglia, Thomas  A Hughes, James  L Thorne" dateCollected="2019-11-03" id="autogum_academic_doc450" shortTile="ernegative-breast" sourceURL="https://www.mdpi.com/2072-6643/11/11/2618/htm" speakerCount="0" speakerList="none" title="ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling" type="academic">
<head>
<s>
1
.
</s>
<s>
Introduction
</s>
</head>
<p>
<s>
Cholesterol
is
predominantly
synthesized
de
novo
in
the
liver
with
lesser
amounts
obtained
from
the
diet
.
</s>
<s>
Dietary
intake
,
de
novo
synthesis
,
metabolism
and
excretion
,
combine
to
balance
circulating
cholesterol
levels
ensuring
extra-hepatic
tissues
are
sufficiently
equipped
to
produce
a
range
of
metabolites
including
steroid
hormones
,
bile
acids
and
seco-steroids
.
</s>
<s>
Side-chain
hydroxycholesterols
(
scOHCs
)
are
typically
formed
through
hydroxylation
of
cholesterol
by
specialized
members
of
the
Cytochrome
P450
family
,
which
bind
and
activate
the
Liver
X
Receptor-alpha
(
LXRA
;
gene
name
<hi rend="italic">
NR1H3
</hi>
)
and
beta
(
LXRB
;
gene
name
<hi rend="italic">
NR1H2
</hi>
)
transcription
factors
.
</s>
<s>
LXR
target
genes
are
typically
involved
in
cholesterol
and
fatty
acid
metabolism
.
</s>
<s>
In
normal
tissue
,
expression
of
LXRA
is
inducible
in
the
liver
,
intestine
,
macrophages
and
adipocytes
,
whilst
expression
of
LXRB
is
more
ubiquitous
.
</s>
<s>
As
well
as
differences
in
expression
of
LXRA
and
LXRB
,
local
concentrations
of
the
scOHCs
differ
considerably
between
tissues
,
and
relative
to
each
other
,
sometimes
by
as
much
as
1000-fold
and
variance
can
also
depend
on
disease
status
.
</s>
<s>
Furthermore
,
the
different
scOHCs
have
varying
capacities
to
activate
LXR-mediated
transcription
,
imposing
an
element
of
selective
modulation
onto
signalling
.
</s>
<s>
26-OHC
(
commonly
referred
to
as
27-OHC
)
for
example
is
the
most
abundant
scOHC
,
but
is
a
relatively
weak
LXR
agonist
.
</s>
<s>
Moreover
,
there
is
little
difference
in
scOHC
concentrations
between
breast
cancer
subtypes
.
</s>
</p>
<p>
<s>
Transcriptional
activity
of
the
LXRs
,
like
the
other
members
of
the
Nuclear
Receptor
(
NR
)
superfamily
,
is
not
just
regulated
by
ligand
bioavailability
;
chromatin
environment
,
cross-talk
and
competition
for
response
element
binding
with
other
NRs
,
as
well
as
cell-
and
tissue-type
dependent
expression
of
cofactors
are
also
key
mediators
.
</s>
<s>
For
example
,
the
expression
of
corepressors
such
as
NCOR1
and
NCOR2/SMRT
determine
how
several
cancers
respond
to
nutritive
ligands
.
</s>
<s>
LXRA
has
a
100-fold
higher
binding
affinity
than
LXRB
for
the
corepressors
NCOR1
and
NCOR2
and
deregulation
of
these
corepressors
allows
prostate
and
bladder
cancer
cells
to
evade
cancer
suppressive
signals
of
Vitamin
D
(
through
repression
of
Vitamin
D
Receptor
(
VDR
)
)
and
omega-3
fatty
acids
(
through
repression
of
peroxisome
proliferator-activated
receptors
(
PPARs
)
)
by
impairing
sensitivity
to
ligand
.
</s>
<s>
Simply
measuring
scOHC
concentrations
does
not
sufficiently
determine
their
contributions
to
LXR
signalling
;
concentration
and
activation
potential
should
be
assessed
in
combination
.
</s>
</p>
<p>
<s>
In
cancer
,
the
function
of
the
scOHC-LXR
signalling
axis
appears
site
specific
as
both
tumour
suppressive
and
promoting
roles
have
been
described
.
</s>
<s>
For
example
,
scOHC-LXR
signalling
impairs
invasion
and
angiogenesis
in
melanoma
and
is
anti-proliferative
in
lung
cancer
in
vivo
,
as
it
is
in
almost
every
cancer
cell
line
studied
in
vitro
.
</s>
<s>
In
Oestrogen
Receptor
(
ER)-positive
Breast
Cancer
(
BCa
)
however
26-OHC
promotes
growth
in
vivo
via
ER-alpha
.
</s>
<s>
In
ER-negative
BCa
26-OHC
drives
the
epithelial-to-mesenchymal
transition
and
promotes
colonization
of
metastatic
sites
in
through
mobilization
of
γδ-T
cells
.
</s>
<s>
Furthermore
,
concentrations
of
several
scOHCs
are
altered
in
BCa
relative
to
normal
tissue
,
and
25-OHC
is
elevated
in
the
circulation
of
BCa
patients
who
have
relapsed
compared
to
those
with
primary
disease
.
</s>
</p>
<p>
<s>
We
recently
evaluated
LXR
ligand
bio-availability
in
a
small
BCa
cohort
and
found
large
inter
tumoural
heterogeneity
in
oxysterol
content
,
but
no
difference
in
ligand
concentrations
between
tumour
subtypes
.
</s>
<s>
Systematic
evaluation
of
scOHC
bioavailability
and
activation
potential
,
coupled
with
analysis
of
NR
cofactor
expression
between
BCa
subtypes
has
not
been
performed
previously
.
</s>
<s>
Given
the
prognostic
and
therapeutic
value
of
stratifying
BCa
by
hormone
receptor
status
,
further
delineation
of
the
pathways
that
are
altered
between
these
subtypes
,
such
as
scOHC-LXR
signalling
,
may
help
advance
understanding
about
the
emerging
roles
of
cholesterol
metabolism
in
cancer
and
improve
outcomes
for
patients
.
</s>
</p>
</text>
